EV/EBITDA
-2.95
-0.06-2.08%
Thu, 06 Mar 2025 00:45:13 GMT
Summary
- As of March 6, 2025, CRDL EV/EBITDA is -2.95, with a fall of -0.06 (-2.08%) during the most recent trading day.
- Over the past year, CRDL EV/EBITDA has increased by +1.17 (+28.40%).
- CRDL EV/EBITDA is now -741.30% below its all-time high of 0.46.
Performance
CRDL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRDL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.1% | +2.0% | +1.8% |
| 1 m1 month | +24.6% | -24.6% | -22.2% |
| 3 m3 months | +24.7% | -24.7% | -22.3% |
| 6 m6 months | +40.8% | -29.2% | -39.8% |
| ytdytd | +14.5% | -14.4% | -12.9% |
| 1 y1 year | +28.4% | -8.8% | -35.4% |
| 5 y5 years | +55.4% | +26.4% | -56.3% |
CRDL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.3% | -3.91 | +24.6% | |
| 3 m | 3-month | -2.75 | -7.3% | -3.92 | +24.7% |
| 6 m | 6-month | -2.75 | -7.3% | -6.66 | +55.7% |
| 1 y | 1-year | -2.75 | -7.3% | -8.40 | +64.9% |
| 3 y | 3-year | 0.46 | -741.3% | -8.40 | +64.9% |
| 5 y | 5-year | 0.46 | -741.3% | -8.40 | +64.9% |
| alltime | all time | 0.46 | -741.3% | -11.35 | +74.0% |
Cardiol Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.95(-14.5%) |
| 2024 | -3.45(+180.5%) |
| 2023 | -1.23(-451.4%) |
| Date | Value |
|---|---|
| 2022 | 0.35(-121.9%) |
| 2021 | -1.60(-59.5%) |
| 2020 | -3.95(-53.4%) |
| 2019 | -8.47 |
FAQ
- What is Cardiol Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cardiol Therapeutics?
- What is CRDL EV/EBITDA year-to-date change?
- What is Cardiol Therapeutics EV/EBITDA year-on-year change?
What is Cardiol Therapeutics EV/EBITDA?
The current EV/EBITDA of CRDL is -2.95
What is the all time high EV/EBITDA for Cardiol Therapeutics?
Cardiol Therapeutics all-time high EV/EBITDA is 0.46
What is CRDL EV/EBITDA year-to-date change?
Cardiol Therapeutics EV/EBITDA has changed by +0.50 (+14.49%) since the beginning of the year
What is Cardiol Therapeutics EV/EBITDA year-on-year change?
Over the past year, CRDL EV/EBITDA has changed by +1.17 (+28.40%)